Fully automated radiosynthesis of [18F]FCPPC for imaging microglia with PET

Pritam Roy1,2,3, Yan Guo1,2,3, Otto Muzik2,4

  • 1Cyclotron and Radiochemistry Core, Karmanos Cancer Institute Detroit, MI, USA.

Insights

We developed an automated method to synthesize [18F]FCPPC, a novel radiotracer for Positron Emission Tomography (PET) imaging. This advancement enables efficient and high-purity production of [18F]FCPPC for human microglia imaging and neuroinflammation studies.

Area of Science:

  • Neuroscience
  • Radiochemistry
  • Medical Imaging

Background:

  • Colony-stimulating factor 1 receptor (CSF1R) is a key marker for microglia in the human brain, making it a potential target for neuroinflammation imaging.
  • [11C]CPPC is a radiotracer for CSF1R, but its fluorine-18 labeled analog, [18F]FCPPC, had low yields with manual synthesis.
  • Efficient and reliable production of [18F]FCPPC is crucial for its clinical application in microglia PET imaging.

Purpose of the Study:

  • To develop and validate a fully automated radiosynthesis of the fluorine-18 labeled radiotracer [18F]FCPPC.
  • To optimize the production of [18F]FCPPC for high radiochemical yield and purity.
  • To establish [18F]FCPPC as a viable tool for human microglia PET imaging.

Main Methods:

  • Automated radiosynthesis of [18F]FCPPC was performed using a Synthra RNplus research module.
  • The synthesis process was optimized for speed and efficiency, aiming for a total synthesis time under 1 hour.
  • Quality control tests were conducted to ensure the radiochemical purity and suitability of the final product for imaging.

Main Results:

  • The automated radiosynthesis yielded [18F]FCPPC in a decay-corrected radiochemical yield of 26.8 ± 0.1% (n=3) within 50 minutes.
  • Radiochemical purities consistently exceeded 99%.
  • The synthesized [18F]FCPPC met all predefined quality control release criteria.

Conclusions:

  • The first fully automated radiosynthesis of [18F]FCPPC has been successfully established.
  • This automated method provides a reliable and efficient way to produce [18F]FCPPC for clinical use.
  • [18F]FCPPC is a promising radiopharmaceutical for non-invasive imaging of microglia density and neuroinflammation in humans.